drugset / Trial / NCT04394442
Hydroxychloroquine in COVID-19 Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
Many reports argued about the possible beneficial effects of Hydroxychloroquine in treating COVID-19 patients and this study was designed to investigate this claim
Timeline
- Start
- 2020-03-21
- Primary completion
- 2020-08
- Completion
- 2020-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydroxychloroquine | Small molecule | 200 mg | — |